In addition, patients with loss of human leukocyte antigen A (HLA-A) and/or HLA-B expression showed statistical significance in one-year PFS (30.9%) compared to patients with HLA-A/HLA-B tumor expression (5.6%). This evidence concerns the gene HLA-A and neoplasm.